StockNews.AI
EHC
StockNews.AI
12 days

Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Haslet, Texas

1. EHC plans to build a 50-bed rehab hospital in Haslet, Texas. 2. The hospital addresses various rehabilitation needs, including neurological disorders. 3. Construction expected to begin soon, with an opening projected for 2027. 4. EHC aims to enhance its Texas presence through this new facility. 5. Encompass Health is the largest operator of inpatient rehabilitation hospitals in the U.S.

8m saved
Insight
Article

FAQ

Why Bullish?

The expansion signifies strong growth prospects and increased market share for EHC.

How important is it?

The announcement of new facilities directly impacts EHC's operational capacity and brand presence.

Why Long Term?

The long-term outlook reflects EHC's expansion strategy in a growing market segment.

Related Companies

HCASRVSAMED
, /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a freestanding, 50-bed inpatient rehabilitation hospital in Haslet, Texas. The hospital will serve patients recovering from debilitating illnesses and injuries, including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions. In addition to 24-hour nursing care, the hospital will offer physical, occupational and speech therapies to restore functional ability and quality of life. Care will be provided by highly specialized nurses, therapists and physicians. The hospital will feature private patient rooms, a spacious therapy gym with advanced rehabilitation technologies and an activities of daily living suite, in-house dialysis suite, dining room, pharmacy and therapy courtyard.  "We are excited to further expand Encompass Health's presence in Texas," said Brad Kennedy, Encompass Health group president. "We look forward to beginning construction of the hospital in Haslet so we can progress toward opening its doors and bringing high-quality inpatient rehabilitative care to the community." The hospital, expected to open in 2027, will be part of Encompass Health's national network of rehabilitation hospitals and its ongoing expansion in Texas. About Encompass Health Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 169 hospitals in 38 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's World's Most Admired Companies™ and Forbes' Most Trusted Companies in America. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook. From Fortune. © 2025 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. From Forbes © 2024 Forbes Media LLC. All rights reserved. Used under license. Forward-Looking Statements Statements contained in this press release which are not historical facts, such as those relating to the likelihood, timing and effects of the completion of this hospital project, are forward-looking statements. In addition, Encompass Health may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Encompass Health's actual results or events may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual results or events to differ materially from those anticipated include, but are not limited to, the regulatory review and approval process, any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings that may be brought by or against the Company; the possibility this project will experience unexpected delays; the ability to successfully complete this project consistent with Encompass Health's growth strategy, including development and maintenance of relationships with referral sources; disease outbreaks, including the speed, depth, geographic reach and duration of the spread; the actions to be taken by Encompass Health in response to disease outbreaks; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and Encompass Health's response thereto; the hospital's ability to maintain proper local, state and federal licensing; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems; Encompass Health's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages and the impact on Encompass Health's labor expenses from potential union activity and staffing shortages; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; general conditions in the economy and capital markets; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended Dec. 31, 2024 and 10-Q for the quarters ended March 31, 2025 and June 30, 2025. Media contact:Polly Manuel | 205-970-5912[email protected] Investor Relations contact: Mark Miller | 205-970-5860[email protected] SOURCE Encompass Health Corp. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News